stockrowZimmer Biomet Holdings, Inc.
ZBH Healthcare Medical Devices
Zimmer Biomet Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $8.2 billion, up 7.20% from fiscal 2024.
- Revenue
- +3.07%
- EPS
- −13.5%
- Free cash flow
- +29.8%
- Total debt
- −7.50%
Quarter to September 2026, against a year earlier
Follow ZBH
Alert me
Zimmer Biomet Holdings, Inc. (ZBH) Total debt
Zimmer Biomet Holdings, Inc.'s total debt at the end of fiscal 2025 was $7.5B, up 21.2% from $6.2B in fiscal 2024. At the end of the quarter to 30 September 2026 it was $7.5B. Over the past ten years it has ranged from $5.7B (fiscal 2022) to $11.5B (fiscal 2015); the current reading is higher than 45% of that period. Zimmer Biomet Holdings, Inc. ranks 7th of 147 Medical Devices companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $7.5B | 21.19% |
| FY2024 | $6.2B | 7.57% |
| FY2023 | $5.8B | 1.25% |
| FY2022 | $5.7B | (19.41%) |
| FY2021 | $7.1B | (13.02%) |
| FY2020 | $8.1B | (1.15%) |
| FY2019 | $8.2B | (8.02%) |
| FY2018 | $8.9B | (11.87%) |
| FY2017 | $10.1B | (9.78%) |
| FY2016 | $11.2B | (2.23%) |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Sep 2026 | $7.5B | 0.34% |
| Jun 2026 | $7.5B | 0.11% |
| Mar 2026 | $7.5B | (0.64%) |
| Dec 2025 | $7.5B | (7.32%) |
| 43 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| PHG Koninklijke Philips N.V. compare | $8.0B |
| ZBH Zimmer Biomet Holdings, Inc. | $7.5B |
| SNN Smith & Nephew SNATS, Inc. compare | $3.2B |
| STE STERIS plc compare | $1.9B |
| DXCM DexCom, Inc. compare | $1.2B |
| PODD Insulet Corporation compare | $962.1M |
| GMED Globus Medical, Inc. compare | $443.4M |
| GKOS Glaukos Corporation compare | $66.9M |
| PEN Penumbra, Inc. compare | $19.0M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on ZBH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement